Tag: Pfizer

Pfizer’s COVID Pill Paxlovid Inching Closer to Getting FDA Approval

An advisory committee from the U.S. Food and Drug Administration (FDA) has voted in favor of approving a new drug application for Pfizer’s COVID pill Paxlovid, even as potential drug interaction risks were highlighted during the committee meeting. Paxlovid is an oral antiviral pill that has been available for use in the United States since…


LIVE NOW: FDA Advisers Meet to Discuss Pfizer’s COVID-19 Pill

The Antimicrobial Drugs Advisory Committee, which advises the U.S. Food and Drug Administration, meets at 9 a.m. ET on March 16 to discuss a new application for Pfizer’s Paxlovid pill for oral use. The pill treats mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID 19, including hospitalization or death….


Israeli Ministry of Health Produces Controversial Report on COVID-19 Vaccine Mortality

An Israeli Ministry of Health (MOH) study could not determine mortality risk from Pfizer’s COVID-19 vaccine and found no evidence of cardiovascular events after COVID-19 vaccination, the MOH said, though an outside expert said the conclusions are contrary to the data. The study (pdf) was published in Hebrew on the MOH website on Feb. 27….


Emails Show Journal’s Discussion Before Rejecting Paper Challenging Pfizer’s Claim of 95 Percent Vaccine Effectiveness

Officials at a major journal discussed a professor’s alleged anti-vaccine Twitter activity when considering whether to publish his paper challenging the claim that Pfizer’s vaccine was 95 percent effective, newly disclosed emails show. The Lancet journal ultimately rejected the rebuttal paper. Professor Norman Fenton “retweeted anti-vaxx posts on Twitter,” one Lancet official wrote to colleagues….


Emails Reveal Journal’s Internal Discussions Before Rejecting Challenge to Pfizer’s Effectiveness Claim

Officials at a major journal discussed a professor’s alleged anti-vaccine Twitter activity when considering whether to publish his paper challenging the claim that Pfizer’s vaccine was 95 percent effective, newly disclosed emails show. The Lancet journal ultimately rejected the rebuttal paper. Professor Norman Fenton “retweeted anti-vaxx posts on Twitter,” one Lancet official wrote to colleagues….


FDA Authorizes Updated COVID-19 Vaccine for Children as Young as 6 Months Old

The U.S. Food and Drug Administration (FDA) has granted emergency authorization to the updated Pfizer-BioNTech COVID-19 vaccine as a booster for children as young as 6 months old, even though Pfizer has produced no clinical efficacy data for any age group. FDA officials on March 14 said the emergency clearance was based on trial data…


It’s Time to Restore Ethical Integrity at the University of British Columbia

Commentary As a University of British Columbia alumnus, with a Ph.D. from the Department of English Language and Literatures, I share responsibility for UBC’s policies. Because my credentials are associated with UBC, whenever I make use of them to gain employment, or to secure positions as a volunteer or committee member, whenever I draw benefit…


Industry Minister Met With Pfizer to Expand Collaboration

Canada’s minister of industry met with executives from pharmaceutical giant Pfizer in New York City on March 2 to discuss expanding collaboration, his office says. “They discussed how we can collaborat[e] in multiple areas to expand our growing biomanufacturing and life sciences sector,” said Laurie B. Bouchard, spokesperson to Minister François-Philippe Champagne. “New areas of…


US Invested in mRNA Vaccines for Decades Pre-Pandemic

In the first study to systematically examine the public investments in mRNA vaccines, researchers have found that the U.S. government was substantially invested in COVID-19 decades before the pandemic. Published in the British Medical Journal on March 3, the study found that the government invested $31.9 billion in mRNA vaccines and technologies between 1985 and…


90 Million COVID Vaccines Making Their Way to Canada: Federal Records

Over 90 million COVID-19 vaccines are making their way to Canada, federal records show. “Under Canada’s advance purchase agreements there are currently 90.8 million remaining doses to be delivered in 2023 and 2024,” said a Department of Public Works report to the Commons public accounts committee (PACP), as first reported by Blacklock’s Reporter. Prices were…